Cardiac resynchronization therapy (CRT) is achieved by implanting a biventricular pacemaker (BiV) into patients suffering from congestive heart failure secondary to a dilated cardiomyopathy. Congestive heart failure patients are first treated with standard heart failure drug therapy; however, if this therapy is not sufficient and the patients meet specific criteria, they can be selected for CRT. This therapy can create vast cardiac and symptomatic improvements in a relatively short time. This case report discusses the characteristics of a dilated cardiomyopathy before and after CRT and the associated cardiac improvements. Sonography continues to play an important role in diagnosing dilated cardiomyopathies, as well as congestive heart failure, and monitoring the progression after treatment.
A woman in her mid-40s presented to her cardiologist with prominent shortness of breath, chest tightness, and dizzy spells associated with nausea, vomiting, and abdominal pain. She was found to have cardiomegaly on a previous chest x-ray. An electrocardiogram and Bio-Z (CardioDynamics, The ICG Company, San Diego, CA) were obtained and showed sinus rhythm at a rate of 98 beats per minute (bpm) with a left bundle branch block and a QRS duration of 138 ms. The Bio-Z showed a low cardiac index with elevated systemic vascular resistance and normal thoracic fluid content. An echocardiogram was performed using American Society of Echocardiography guidelines using a Sequoia (ACUSON Corporation, A Siemens Company, Mountain View, CA). 1 A multifrequency phased-array probe was used with an operating fre-quency of 2.0 to 4.0 MHz with Harmonics. She had mild left ventricular end-diastolic enlargement measuring 6.67 cm, consistent with a dilated cardiomyopathy, and a severe decrease in left ventricular systolic function with a calculated ejection fraction (EF) of 35%, although it appeared to be less. There was mild left atrial enlargement measuring 4.25 cm. She also had severe mitral valve regurgitation with a normal appearance of mitral valve anatomy (Figs. 1, 2). Mild tricuspid valve regurgitation and mild pulmonary hypertension were detected with a right ventricular systolic pressure of 39 mmHg. The right-sided chambers were within normal limits, and there was no pericardial effusion.
The following day, she underwent a detailed left and right heart catheterization. The right ventricular systolic pressure measured 55 mmHg. The left ventricle was mildly dilated, with an estimated EF of 20% and 3 to 4+ mitral valve regurgitation. The coronary arteries were all normal.
She was then evaluated for heart failure and cardiac transplant. The etiology of the dilated cardiomyopathy was unclear and warranted further evaluation before cardiac transplantation. She was placed on an aggressive congestive heart failure drug therapy regimen and evaluated regularly.
A six-month follow up revealed increased shortness of breath, chest pain, fatigue, and New York Heart Association (NYHA) functional therapeutic class (FTC) III-IV congestive heart failure. An electrocardiogram and Bio-Z were obtained and showed sinus rhythm at a rate of 72 bpm with a left bundle branch block and a QRS duration of 144 ms. The Bio-Z showed decreased cardiac output, with elevated systemic vascular resistance and mildly decreased thoracic fluid content. She was scheduled for insertion of a biventricular pacemaker (BiV) for CRT.
One month after BiV (Medtronic InSync pacemaker, model #8040) insertion, she presented with shortness of breath, fatigue, low energy, and dyspnea on exertion. An electrocardiogram showed sinus bradycardia at a rate of 54 bpm with a short PR interval and paced QRS. The BiV was reprogrammed and set at a rate of 70 bpm, with the dual-chamber pacing rate response turned on. A post-CRT echocardiogram was obtained and showed marked improvement. There was mild left ventricular end-diastolic enlargement measuring 5.99 cm, with a calculated EF of 38% and mild to moderate mitral valve regurgitation (Figs. 3, 4) . The left atrium and the right heart chambers were normal in size and function.
At her two-week follow-up, she had lessoned shortness of breath and NYHA FTC II-III. On evaluation, her heart rate was 72 bpm at a regular rate and rhythm.
Discussion
Heart failure currently affects nearly 5 million people in the United States and continues to increase rapidly. 2, 3 It is caused by injuries to the heart such as myocardial infarctions, untreated hypertension, valvular disease, or dilated cardiomyopathies. 2, 4 Current treatments include heart transplantation, coronary artery bypass grafts (CABG), drug therapy, and CRT. 3 CRT is a relatively new treatment used for chronic heart failure. A BiV is implanted into patients with severe heart failure (NYHA FTC III-IV). 5 To be selected for CRT, these patients must also have intraventricular conduction delays characterized by wide QRS complexes (> 120 ms), usu-ally noticeable as a left bundle branch block; dyssynchrony of ventricular contractions; and an EF of < 35%. [4] [5] [6] Patients may also have a primary dilated cardiomyopathy. 7 Dilated cardiomyopathies (DCM) are characterized by dilated left and right ventricles and atria and a decreased left ventricular function or EF. 7, 8 Structural abnormalities of the myocardium also affect the contraction of the ventricle. 4 Intraventricular conduction defects or delays are associated with such abnormalities. 7 Mitral regurgitation almost always coexists with dilated cardiomyopathies secondary to left ventricular dilatation and possibly intraventricular conduction delays. 8, 9 If left untreated, a patient with this type of heart disease could suffer from systemic embolization and neurological episodes from thrombus formation in the left heart. 7 CRT can decrease the signs and symptoms of chronic heart failure and dilated cardiomyopathies by improving the synchrony of the right and left ventricular contractions. 4 The three BiV pacing leads responsible for resynchrony are placed in the right atrium, right ventricle, and the left ventricle. The left ventricular lead is implanted into the distal cardiac vein through the coronary sinus. 9 After implantation, the atrial-synchronized biventricular pacing is started.
Studies have shown that patients with BiV pacing, along with congestive heart failure drug therapy, experience improved quality of life and lessoned symptoms. 4, 5, 9 This improvement is achieved by an increased EF, a decrease in left ventricular end-diastolic internal dimension, a decreased QRS interval, and lessoned mitral regurgitation. 4, 5, 9 Comments This case report illustrates the sonographic characteristics of a patient with a dilated cardiomyopathy as well as congestive heart failure before and after cardiac resynchronization therapy by implantation of a BiV pacing device. CRT, used hand in hand with standard heart failure drug therapy, allows patients a better quality of life by decreasing the signs and symptoms through resynchronization of the ventricles. In turn, the systolic function increases while ventricular dimensions and the amount of mitral regurgitation decrease lessoning symptoms. Because of the possible severity of such heart disease, treatment is necessary.
This case is important to all cardiac sonographers because of the cardiac improvement after CRT. These improvements occur in a short time after CRT and can create confusion if a thorough history is not known. CRT is being used more often as studies are conducted, and sonographers will continue to see cardiac changes accordingly.
